Shira Zelber‐Sagi

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Sadaf G Sepanlou, Saeid Safiri, Catherine Bisignano et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 1.6K citations · Full text

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong et al. · Journal of Hepatology · 2024 · 1.2K citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +14

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study

Shira Zelber‐Sagi, Dorit Nitzan, Rebecca Goldsmith et al. · Journal of Hepatology · 2007 · 550 citations

Obesity, Metabolic Syndrome, Nutrition +14

A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver Disease

Shira Zelber‐Sagi, Ada Kessler, Eli Brazowsky et al. · Clinical Gastroenterology and Hepatology · 2006 · 314 citations · Full text

Obesity, Metabolic Syndrome, Hepatology +7

Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study

Shira Zelber‐Sagi, Dorit Nitzan, Rebecca Goldsmith et al. · Hepatology · 2008 · 299 citations · Full text